FTC: injunction denial threatens future enforcement

The Federal Trade Commission need not show an imminent likelihood that Shire ViroPharma would break the law before obtaining an injunction based on the company’s prior conduct, the commission has told the US Court of Appeals for the Third Circuit.

Get unlimited access to all Global Competition Review content